Metformin and Malignant Tumors: Not Over the Hill
Weiling Leng,1,* Juan Jiang,2,* Bing Chen,1 Qinan Wu3 1Endocrinology Department, The First Affiliated Hospital of the Third Military Medical University (Army Medical University), Chongqing, People’s Republic of China; 2Endocrinology and Nephrology Department, Chongqing University Cancer Ho...
Guardado en:
Autores principales: | Leng W, Jiang J, Chen B, Wu Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/006ef183f96249318c689f215edb1891 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Metformin and Malignant Tumors: Not Over the Hill [Response to Letter]
por: Leng W, et al.
Publicado: (2021) -
Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
por: He X, et al.
Publicado: (2020) -
Long‐term Risk of Malignant Neoplastic Disorders in Type 2 Diabetes Mellitus Patients with Metabolic Syndrome
por: Albai O, et al.
Publicado: (2020) -
Metformin and Malignant Tumors: Not Over the Hill: A Short Comment [Letter]
por: Rastmanesh R
Publicado: (2021) -
Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus
por: Zhang Q, et al.
Publicado: (2020)